Stifel Financial’s Aprea Therapeutics APRE Stock Holding History

Stifel Financial’s Portfolio APRE Stock Details APRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$3.31K	–	3325
2022 Q4	$3.31K	Hold	500	–	–	﹤0.01%	3279
2022 Q3	$7K	Hold	500	–	–	﹤0.01%	3264
2022 Q2	$8K	Hold	500	–	–	﹤0.01%	3304
2022 Q1	$19K	Buy	+500	New	+$20.5K	﹤0.01%	3343

Other funds holding APRE

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Stifel Financial's APRE Position: Q1 2023 in Review

Stifel Financial sold out of Aprea Therapeutics (APRE) in Q1 2023, closing a stake of 500 shares — an estimated $3.31K sold.

Stifel Financial first reported a position in APRE in Q1 2022 and held it in 4 quarters. The position peaked at $19K in Q1 2022. 18 funds tracked by Wall St. Rank hold APRE as of Q1 2023.

Stifel Financial reported no remaining Aprea Therapeutics position as of Q1 2023 after selling out during the quarter.
Stifel Financial sold 500 Aprea Therapeutics shares in Q1 2023, an estimated $3.31K.
Stifel Financial first reported a position in Aprea Therapeutics in Q1 2022 and held it in 4 quarters.
Stifel Financial's Aprea Therapeutics position peaked at $19K in Q1 2022.
18 funds tracked by Wall St. Rank held Aprea Therapeutics as of Q1 2023.

Based on Stifel Financial's 13F filing for Q1 2023, filed 12 May 2023.